MCCURDY, Sean
$150,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2013-2014
Canada
A novel use of E2f and Cdk inhibitors to prevent RB1-null tumors in genetically engineered models of retinoblastoma and other cancers